Animal studies show cannabis has anti-inflammatory and anti-diarrheal properties, and human studies show symptom and quality-of-life improvements, but no study has demonstrated actual disease modification in IBD as measured by biomarkers or endoscopic healing.
IBD patients curious about cannabis, gastroenterologists, and medical cannabis researchers.
Symptom relief observed but no disease modification confirmed
What the researchers found
Preclinical data demonstrate cannabinoid anti-inflammatory, antidiarrheal, and pain-limiting properties. Human studies show benefits in symptom control and quality of life, but biomarker profiles and endoscopic healing have not improved, meaning the underlying disease process appears unaffected.
Why it matters
IBD patients frequently ask about cannabis, and many self-medicate. The disconnect between symptom relief and disease modification is critical information for making informed decisions.
The numbers in context
No specific patient counts provided. Review covered preclinical animal models, human clinical studies, and safety data across the existing literature.
How the study worked
White paper reviewing preclinical data, clinical studies, safety data, and the regulatory landscape for medical cannabis use in inflammatory bowel disease.
What this study cannot tell us
Narrative review without systematic search methodology. Federal Schedule I classification limits the quality and quantity of available research.
How to read the evidence
Comprehensive review of existing evidence, but the underlying studies are limited in number and quality.
When this study was published
2019 white paper.
The bigger picture
The finding that cannabis may improve how patients feel without changing the underlying disease is important. Symptom relief matters, but hidden inflammation can still cause long-term damage.
Questions still open
- Could specific cannabinoid formulations or doses actually modify IBD disease activity? Does symptom masking from cannabis lead patients to delay necessary medical treatment?
Common questions
Does cannabis help with inflammatory bowel disease?
What effects does cannabis have on the gut in animal studies?
Read the original research
The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information.
Inflammatory bowel diseases, 25(3), 427-435
Citation
Swaminath, Arun; Berlin, Eric P; Cheifetz, Adam; Hoffenberg, Ed; Kinnucan, Jami; Wingate, Laura; Buchanan, Sarah; Zmeter, Nada; Rubin, David T. (2019). The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information.. Inflammatory bowel diseases, 25(3), 427-435. https://doi.org/10.1093/ibd/izy319
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk